Peptide Reconstitution
Legal Disclaimer
All information provided on this website is intended strictly for informational and educational purposes within the context of in-vitro scientific research.
The products offered are for laboratory research use only and are not drugs, medicines, dietary supplements, or cosmetics. These materials have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for any medical, diagnostic, therapeutic, or veterinary use.
All products are intended solely for qualified professionals conducting controlled in-vitro studies performed outside of living organisms. Any form of administration, application, or introduction into the human or animal body is strictly prohibited by law.
By purchasing or handling these materials, the buyer agrees that use is limited to lawful research activities and acknowledges that Regentide and its affiliates assume no liability for misuse or handling contrary to these terms.
Lyophilized Peptides
Peptides are typically supplied as a lyophilized (freeze-dried) powder to support stability. Lyophilization removes water under vacuum, leaving a dry “puck” or powder with a fluffy or granular appearance, depending on composition and processing method.
Reconstitution in Laboratory Settings
Prior to in-vitro use, peptides must be reconstituted—dissolved in an appropriate laboratory-grade solvent. There is no universal solvent for all peptides; the correct choice depends on polarity, charge, and stability profile.
Preferred Starting Solvents
- Sterile distilled water or sterile research-grade diluents suitable for in-vitro applications.
- Avoid sodium chloride (saline) solutions due to potential precipitation with certain acetate-form peptides.
Polarity-Based Guidance
- Basic peptides: use mildly acidic research solutions.
- Acidic peptides: use mildly basic research solutions.
- Hydrophobic / neutral: may require trace amounts of organic lab solvents (e.g., acetic acid, ethanol, propanol, isopropanol, DMSO).
- Contains methionine/cysteine: avoid DMSO due to oxidation risk.
Best-Practice Guidelines
- Assess solubility on a small sample before reconstituting a full vial.
- Begin with low-strength, easily removable solvents (e.g., sterile water or ≤0.1% acetic acid).
- If insoluble, remove the solvent and retry with a more suitable option based on peptide polarity.
- Prepare higher-concentration stock solutions to facilitate later dilution and handling.
- Avoid using the final assay buffer as the first solvent unless solubility is pre-confirmed.
Sonication
Sonication can help disperse visible particulates but does not increase intrinsic solubility. After sonication: clear solutions suggest dissolution, while cloudy/gel-like outcomes indicate suspended material. If insoluble, repeat with an appropriate solvent compatible with in-vitro protocols.
Compliance Statement
Regentide maintains compliance with applicable FDA RUO labeling regulations (21 CFR § 809.10(c)(2)(i)). No materials are offered, marketed, or implied for human or animal administration under any circumstance. All educational content herein serves the advancement of legitimate scientific research only.